Global X HealthTech ETF (HEAL)
Financial Services · Asset Management · NASDAQ · US
$28.10-1.37%At close 2026-07-14
BUYRECOVERY · day 24
Key stats
- Market cap
- $42M
- From ATH
- -16.20%
- Avg volume
- 8.2K
- Div yield
- 0.26%
- Beta
- 1.47
1W-3.67%
1M+7.87%
3M+13.81%
YTD-4.10%
Company news
Restart Life Sciences Leverages University of Manitoba RCFTR Collaboration for Pre-Production Transition of New Protein Frameworks
Restart Life Sciences Details Next-Generation Product Pipeline and Segment Expansion for Holy Crap
Restart Life Sciences Reports Record-Breaking June Revenue for Holy Crap Foods as Amazon Canada Sales Surge YoY
Restart Life Advances AI-Driven E-Commerce Strategy to Scale Online Sales Growth for Holy Crap Foods
Restart Life Subsidiary Holy Crap Foods Marks New International Expansion Milestone with Bahamas On-Demand App Launch
Restart Life Sciences Appoints Inez Ho as Chief Financial Officer
Restart Life Sciences Closes Dedicated Purchase Order Financing Private Placement; CEO Subscribes for 50% of Offering
Medicine's Not Going Anywhere: 3 of the Most Resilient Healthcare ETFs
Restart Life Sciences Advances New Product Relaunch Utilizing Acquired Intellectual Property Portfolio
Restart Life Sciences Leverages Amazon Logistics for Strategic Entry of Holy Crap Foods into U.S. Market
Restart Life Sciences Announces Dedicated Purchase Order Financing Through Private Placement Offering
Restart Life Sciences Strengthens Operational Infrastructure to Scale "Better-for-You" Portfolio
Restart Life Sciences Reports Holy Crap Foods Revenue Gains of 46% in Wholesale and 32% via Amazon Channels YoY
Restart Life Advances Holy Crap Growth Strategy with New Protein SKU Nearing Commercialization
Restart Life Sciences' Wholly Owned Subsidiary Holy Crap Foods Reports over 500,000 Units Sold, Highlighting Strong Consumer Adoption
Restart Life Sciences Provides Performance and Revenue Trend Update on Newly Acquired Superseed Cereals and Oatmeal Brand Portfolio
